Navigation Links
China Medical Technologies to Announce Results for the Fourth Fiscal Quarter and Full Fiscal Year Ended March 31, 2011 on June 2, 2011
Date:4/27/2011

BEIJING, April 27, 2011 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based advanced in-vitro diagnostic ("IVD") company, today announced that it will report its unaudited financial results for the fourth fiscal quarter ("4Q FY2010") and the full fiscal year ended March 31, 2011 ("FY2010") before the U.S. market opens on June 2, 2011.

The Company will also provide outlook for the first fiscal quarter ending June 30, 2011 as well as the full fiscal year ending March 31, 2012 in the results announcement.

The Company's senior management will host an earnings conference call at 8:00 a.m. U.S. Eastern Time on June 2, 2011 (8:00 p.m. Beijing/Hong Kong time on June 2, 2011).

Conference CallThe dial-in details for the live conference call are as follows:- U.S. Toll Free Number 1-800-215-2410- International Dial-in Number 1-617-597-5410Passcode: CMEDCALLA live webcast of the conference call will be available on http://ir.chinameditech.com.

A replay of this webcast will be available for one month on this website.

A telephone replay of the call will be available after the conclusion of the conference call through 10:00 a.m. U.S. Eastern Time on June 3, 2011.  The dial-in details for the replay are as follows:

- U.S. Toll Free Number 1-888-286-8010- International Dial-in Number 1-617-801-6888Passcode: 61583099About China Medical Technologies, Inc.China Medical Technologies, Inc. is a leading China-based advanced IVD company using molecular diagnostic technologies including Fluorescent in situ Hybridization (FISH) and Surface Plasmon Resonance (SPR) and an immunodiagnostic technology, Enhanced Chemiluminescence Immunoassay (ECLIA), to develop, manufacture and distribute diagnostic products used for the detection of various cancers, diseases and disorders as well as companion diagnostic tests for targeted cancer drugs. The Company generates all of its revenues in China through the sale of diagnostic consumables including FISH probes, SPR-based DNA chips and ECLIA reagent kits to hospitals which are recurring users of the consumables for their patients. The Company sells FISH probes and SPR chips to large hospitals through its direct sales personnel and ECLIA reagent kits to small and mid-size hospitals through distributors. For more information, please visit http://www.chinameditech.com.

ContactWinnie YamTel: 852-2511-9808Email: IR@chinameditech.com
'/>"/>

SOURCE China Medical Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. China Botanic Pharmaceutical Announces Plans to Switch to Renewable Bio-Fuel - Straw Pellets
2. China Shenghuo Announces New Chief Financial Officer
3. Tens of thousands of buyers including Coles Group, El Corte Ingles, Kingfisher, Sears, The Home Depot and Tesco registered to attend China Sourcing Fairs
4. Medical Care Technologies Inc. Signs Letter of Intent for Joint Venture in China
5. China Botanic Pharmaceutical Provides Update on Badger Oil Sales
6. Varian Medical Systems to Exhibit the Latest Digital Image Detectors, X-Ray Tubes and Cancer Treatment Technologies at the CMEF Show in Shenzhen, China
7. Reportlinker Adds ENT Devices Market Outlook in China to 2017 - Hearing Aid Devices and Implants and Diagnostic Devices
8. Canton Fair: Chinas Greatest Trade Fair to Open in April
9. China Botanic Pharmaceutical Approved to Produce Water-Based Mixtures
10. C3i Opens Asia Language Center in Dalian, China
11. China Sky One Medical Obtains Production Licenses for Thirteen New Medical Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/31/2016)... Mich. , May 31, 2016  Diplomat Pharmacy, Inc. ... pharmacy, has announced that Phil Hagerman , Chairman & ... the upcoming William Blair 36 th Annual Growth Stock ... Mr. Hagerman and Mr. Whelan are scheduled to present at ... Central Time. A live audio-only webcast of the presentation and ...
(Date:5/31/2016)... , May 31, 2016 ... ingredient in food, cosmetics and pharmaceuticals, with global volume ... worth US$ 1.6 Bn. Demand for aloe ... juices, and yogurts will continue its upward momentum in ... will also boost positive sentiment on aloe vera, with ...
(Date:5/31/2016)... , Isansys  Lifecare, a new generation digital healthcare ... wireless patient monitoring platform, as it ships more systems to hospitals ... Scotland and Norway ... launched earlier this year, is now being used in ground-breaking ... new technology significantly enhances the user experience and provides ...
Breaking Medicine Technology:
(Date:5/31/2016)... CA (PRWEB) , ... May ... ... approach to healthcare that considers individuals’ genetic characteristics and the physical and ... precision therapy work in sync. In personalized medicine, diagnosing an individual’s disease ...
(Date:5/31/2016)... ... 2016 , ... More than 80 representatives of the Hepatitis B Foundation ... Foundation held an event on National Hepatitis Testing Day outside of Philadelphia City Hall ... leading cause of liver cancer. , Foundation leaders and the citywide coalition they created, ...
(Date:5/31/2016)... San Jose, CA (PRWEB) , ... May 31, 2016 , ... ... collaboration , announces its strategic partnership with e-Jan Networks Co., the leading provider ... Japan enterprises are customers of e-Jan Networks’s leading CACHATTO remote access solution. ...
(Date:5/31/2016)... ... ... years ago it was revolutionary: enabling the people who hear distressing voices to speak ... approach has proven transformative, both for people who hear voices and for the field ... around the world, but it still lags in the United States. , Now, Gail ...
(Date:5/31/2016)... Fort Walton Beach, Florida (PRWEB) , ... May ... ... weather-forecasting technology to Jay Butch of CertainTeed Corporation, he knew it was something ... technology is as state-of-the-art and cutting-edge as it gets,” says Butch, CertainTeed’s Director ...
Breaking Medicine News(10 mins):